Alirocumab (anti-PCSK9)
Online Inquiry
* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Alirocumab (anti-PCSK9)

Cat. No: CDIA-0947
CAS. No.: 1245916-14-6
Synonyms: REGN 727(anti-PCSK9); SAR 236553 (anti-PCSK9)
Size: 5 mg
Price: Inquiry
Product Details
Appearance Liquid
Purity 99.00%
Smiles String [Alirocumab (anti-PCSK9)]
Storage & Handling
Shipping Shipping with dry ice.
Storage Please refer to the instruction manual.

Description

Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia.

! For research use only. Not intended for any clinical use.